Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines - CRCL-OncoPharmacologie Access content directly
Journal Articles Cells Year : 2021

Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines

Abstract

Enzymes of nucleoside and nucleotide metabolism regulate important cellular processes with potential impacts on nucleotide-unrelated parameters. We have used a set of CRISPR/Cas9-modified cell models expressing both, one, or none of the 5′-nucleotidases cN-II and CD73, together with RNA sequencing and targeted metabolomics, to decipher new regulatory roles of these proteins. We observed important transcriptional modifications between models as well as upon exposure to adenosine. Metabolite content varied differently between cell models in response to adenosine exposure but was rather similar in control conditions. Our original cell models allowed us to identify a new unobvious link between proteins in the nucleotide metabolism and other cellular pathways. Further analyses of our models, including additional experiments, could help us to better understand some of the roles played by these enzymes.
Fichier principal
Vignette du fichier
Cadassou O 2021 Cells.pdf (2.09 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-03810114 , version 1 (18-07-2023)

Identifiers

Cite

Octavia Cadassou, Prescillia Forey, Christelle Machon, Edoardo Petrotto, Kamel Chettab, et al.. Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines. Cells, 2021, 10 (11), pp.2918. ⟨10.3390/cells10112918⟩. ⟨hal-03810114⟩
30 View
6 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More